Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1975-03-19
1977-09-20
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
26023975, 424228, 424289, 424DIG13, A61K 31625, C07D23944
Patent
active
040498026
ABSTRACT:
Zinc is essential in the complex process of wound healing. Zinc sulfadiazine promotes wound healing and controls infection. When taken into the body, such as by topical application to a wound surface, zinc sulfadiazine dissolves and its dissociation achieves a replacement of zinc lost in the body fluids, such as in the urine, after thermal or other trauma. Although both zinc sulfadiazine and silver sulfadiazine each effectively controls infection and enhances healing in burn wounds, the combination of zinc sulfadiazine and silver sulfadiazine, particularly in a single medicament, possesses enhanced efficacy.
REFERENCES:
patent: 3761590 (1973-09-01), Fox
Chemical Abstracts, 48: 3918i (1954).
"The Effect of Zinc Supplementation on Wound Healing of Burn Patients", Am. Burn Assoc. Abst. (1976).
Research Corporation
Schenkman Leonard
LandOfFree
Zinc sulfadiazine and its use in the treatment of burns does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zinc sulfadiazine and its use in the treatment of burns, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zinc sulfadiazine and its use in the treatment of burns will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-671711